News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,650 Results
Type
Article (39054)
Company Profile (279)
Press Release (646317)
Section
Business (203867)
Career Advice (1991)
Deals (35364)
Drug Delivery (85)
Drug Development (80800)
Employer Resources (168)
FDA (16089)
Job Trends (14805)
News (344549)
Policy (32437)
Tag
Academia (2530)
Alliances (49088)
Alzheimer's disease (1229)
Approvals (16021)
Artificial intelligence (130)
Bankruptcy (352)
Best Places to Work (11538)
Biotechnology (200)
Breast cancer (120)
Cancer (1087)
Cardiovascular disease (97)
Career advice (1660)
Cell therapy (234)
Clinical research (64252)
Collaboration (388)
Compensation (200)
COVID-19 (2530)
C-suite (94)
Data (1126)
Diabetes (152)
Diagnostics (6139)
Earnings (84821)
Employer resources (146)
Events (109490)
Executive appointments (310)
FDA (16628)
Funding (353)
Gene therapy (178)
GLP-1 (577)
Government (4325)
Healthcare (18669)
Infectious disease (2615)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16304)
Job creations (3624)
Job search strategy (1417)
Layoffs (412)
Legal (7853)
Lung cancer (170)
Manufacturing (176)
Medical device (13174)
Medtech (13179)
Mergers & acquisitions (19141)
Metabolic disorders (402)
Neuroscience (1504)
NextGen Class of 2024 (6499)
Non-profit (4464)
Northern California (1481)
Obesity (232)
Opinion (179)
Patents (102)
People (56274)
Phase I (19955)
Phase II (28303)
Phase III (21099)
Pipeline (458)
Postmarket research (2554)
Preclinical (8494)
Radiopharmaceuticals (236)
Rare diseases (219)
Real estate (5890)
Regulatory (21525)
Research institute (2309)
Resumes & cover letters (349)
Southern California (1302)
Startups (3562)
United States (13500)
Vaccines (549)
Weight loss (168)
Date
Today (77)
Last 7 days (667)
Last 30 days (3716)
Last 365 days (35685)
2024 (32752)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31484)
2015 (37553)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (192)
Asia (37126)
Australia (6059)
California (3331)
Canada (1295)
China (252)
Colorado (147)
Connecticut (153)
Europe (79506)
Florida (461)
Georgia (116)
Illinois (341)
Indiana (196)
Kansas (96)
Maryland (575)
Massachusetts (2611)
Michigan (158)
Minnesota (273)
New Jersey (957)
New York (964)
North Carolina (702)
Northern California (1481)
Ohio (139)
Pennsylvania (847)
South America (1091)
Southern California (1302)
Texas (465)
Utah (90)
Washington State (362)
685,650 Results for "neurometrix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
NeuroMetrix Reports Q1 2024 Business Highlights
NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2024.
May 15, 2024
·
5 min read
Press Releases
NeuroMetrix Reports Q3 2024 Business Highlights
November 5, 2024
·
5 min read
Genetown
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
NeuroMetrix, Inc. announced two steps to enhance shareholder value following feedback and recommendations from one of its largest shareholders, Ephraim Fields of Echo Lake Capital.
April 19, 2024
·
2 min read
Business
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call
NeuroMetrix, Inc. announced that it plans to issue its 2023 fourth quarter and year end business and financial highlights before the opening of the market on February 22, 2024.
February 15, 2024
·
1 min read
Business
NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call
July 31, 2024
·
1 min read
Genetown
NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy
NeuroMetrix, Inc. noted the recent publication of a large study demonstrating that DPNCheck® combined with standard EKG or DPNCheck alone accurately detects diabetic peripheral neuropathy.
March 14, 2024
·
2 min read
Business
NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights
NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and full year ended December 31, 2023.
February 22, 2024
·
7 min read
Genetown
NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia
NeuroMetrix, Inc. (NASDAQ: NURO) today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic commercial launch in December 2022.
March 13, 2024
·
2 min read
Genetown
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value
NeuroMetrix, Inc. announced a process to review strategic options to promote growth of its Quell® neuromodulation and DPNCheck® neurodiagnostic businesses and to maximize shareholder value.
February 13, 2024
·
2 min read
Genetown
NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024
NeuroMetrix, Inc. (Nasdaq: NURO), announced today that it will present at the Emerging Growth Conference on January 10, 2024.
January 8, 2024
·
2 min read
1 of 68,565
Next
